Mark E Gustafson

Title: Mark E Gustafson: Innovator in Tissue Factor Pathway Inhibitor Production

Introduction

Mark E Gustafson is a notable inventor based in St. Charles, MO (US). He has made significant contributions to the field of biochemistry, particularly in the production of tissue factor pathway inhibitors. His innovative methods have the potential to impact various medical applications.

Latest Patents

Mark E Gustafson holds a patent for a method of producing tissue factor pathway inhibitor (TFPI). This method involves the expression of a non-glycosylated form of TFPI in E. coli as a host. The process includes obtaining a highly active TFPI through in vitro refolding of the protein. Inclusion bodies isolated from the E. coli cells undergo stepwise purification, which can follow either series (A) or series (B). This patent showcases his expertise in protein production and purification techniques. He has 1 patent to his name.

Career Highlights

Mark E Gustafson has had a distinguished career, working at Monsanto Company. His role at the company has allowed him to focus on innovative research and development in the field of biotechnology. His work has contributed to advancements in therapeutic applications and has positioned him as a key figure in his area of expertise.

Collaborations

Throughout his career, Mark has collaborated with talented individuals such as Judy A Diaz-Collier and Tze-Chein Wun. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their respective fields.

Conclusion

Mark E Gustafson is a prominent inventor whose work in the production of tissue factor pathway inhibitors has made a lasting impact. His innovative methods and collaborations highlight his commitment to advancing biotechnological research. His contributions continue to influence the field and pave the way for future developments.